Hope Rugo Professor of Medicine; Director, Breast Oncology and Clinical Trials Education; UCSF Comprehensive Cancer Center 5Live #ASCO20
6:09
"Key Insights on A phase Ib study of abemaciclib in combination with pembrolizumab for pts with HR+/HER2- locally advanced or MBC (NCT02779751): Interim results "
Breast Cancer
Hope Rugo Professor of Medicine; Director, Breast Oncology and Clinical Trials Education; UCSF Comprehensive Cancer Center 5Live #ASCO20
"Key Insights on A phase Ib study of abemaciclib in combination with pembrolizumab for pts with HR+/HER2- locally advanced or MBC (NCT02779751): Interim results "
Breast Cancer Similar Videos
Similar Videos
-
Jane Meisel, MD; Emory University Winship Cancer Institute; #DDHO2022
18:32
-
Harnessing the Power of Antibody-Drug Conjugates for the Treatment of Hematologic and Solid Cancer: Leveraging Antibody-Drug Conjugates in Breast Cancer Care_Hope Rugo, MD, FASCO
53:15
-
Cletus Arciero, MD; Emory University Winship Cancer Institute; #DDHO2022
19:22
